New therapies in soft tissue sarcoma

Bruno Vincenzi, Anna Maria Frezza, Daniele Santini, Giuseppe Tonini

Research output: Contribution to journalArticle


Importance of the field: Soft tissue sarcomas are rare mesenchymal tumors accounting for

Original languageEnglish
Pages (from-to)237-248
Number of pages12
JournalExpert Opinion on Emerging Drugs
Issue number2
Publication statusPublished - Jun 2010


  • Anthracycline
  • Ifosfamide
  • Mesenchymal neoplasm
  • MTOR inhibitors
  • Small tyrosine kinase inhibitors
  • Soft tissue sarcoma

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'New therapies in soft tissue sarcoma'. Together they form a unique fingerprint.

  • Cite this

    Vincenzi, B., Frezza, A. M., Santini, D., & Tonini, G. (2010). New therapies in soft tissue sarcoma. Expert Opinion on Emerging Drugs, 15(2), 237-248.